Biomedtech Laboratories Inc is categorized under Electroplating and Plating in Tampa, FL and active since 1998.
Biomedtech Laboratories Inc was established in 1998, and today employs 1 to 4, earning Unknown per year. This is a Electroplating and Plating business, which does work in the B2B market, and is classified as a Electroplating and Plating, under code number 5417115 by the NAICS.
If you are seeking more information, feel free to contact Joachim Sasse at the company’s single location by writing to 3802 Spectrum Boulevard # 154, Tampa, Florida FL 33612 or by phoning (813) 558-2000. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
Business Name: | Biomedtech Laboratories Inc |
Contact Person: | Joachim Sasse |
Address: | 3802 Spectrum Boulevard # 154, Tampa, Florida 33612 |
Phone Number: | (813) 558-2000 |
Website Address: | biomedtech.com |
Annual Revenue (USD): | Unknown |
Founded: | 1998 |
Location Type: | Single Location |
Employee Number: | 1 to 4 |
Business Type: | B2B (Business to Business) |
Business Category: | Electroplating and Plating |
SIC Code: | 3471 |
NAICS Code: | 5417115 |
Share This Business: |
Biomedtech Laboratories Inc was started in 1998 to provide professional Electroplating and Plating under the SIC code 3471 and NAICS code 5417115. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of Unknown per annum.
Feel free to contact Joachim Sasse for inquiries that concern Biomedtech Laboratories Inc by calling the company number (813) 558-2000, as your correspondence is most welcome. Additionally, the physical location of the single location of Biomedtech Laboratories Inc can be found at the coordinates 28.05528,-82.41615 as well as the street address 3802 Spectrum Boulevard # 154 in Tampa, Florida 33612.
For its online presence, you may visit Biomedtech Laboratories Inc’s website at biomedtech.com and engage with its social media outlets through on Twitter and on Facebook.